Mainstream

Stoke Therapeutics GAAP EPS of $1.90, revenue of $158.57M

Stoke Therapeutics GAAP EPS of $1.90, revenue of $158.57M

Post ContentstokRead More

You might also be interested in reading ETHzilla Rebrands to Forum Markets, Pivots Toward Institutional Onchain Infrastructure.

May 13, 2025
In Mainstream